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Role of HIV exposure and infection 
in relation to neonatal GBS disease 
and rectovaginal GBS carriage: 
a systematic review and meta-
analysis
Piet Cools1, Janneke H. H. M. van de Wijgert  2, Vicky Jespers3, Tania Crucitti4,  
Eduard J. Sanders5,6, Hans Verstraelen  7 & Mario Vaneechoutte1
Streptococcus agalactiae (GBS) is the leading cause worldwide of neonatal sepsis. We sought to assess 
to which extent HIV exposure of neonates is associated with GBS neonatal disease. Furthermore, we 
assessed to which extent HIV infection in women is associated with maternal rectovaginal GBS carriage, 
the single most important risk factor for GBS neonatal disease. We searched Pubmed, Embase, and 
Web of Science for studies assessing the association between neonatal GBS disease and HIV-status of 
the mother and studies that assessed the association between rectovaginal GBS colonization and HIV 
status in women. HIV-exposed uninfected neonates were more than twice as likely to have neonatal 
GBS disease compared to unexposed neonates. HIV-exposed neonates were not at increased risk for 
early-onset neonatal disease, but were 4.43 times more likely to have late-onset neonatal GBS disease. 
There was no significant association between HIV infection status and rectovaginal GBS carriage. Public 
health interventions preventing neonatal GBS disease are urgently needed for the increasing group of 
HIV-exposed neonates. A framework integrating and explaining our findings highlights opportunities 
for the clinical practice and global health policy to prevent disease. Well-designed studies should clarify 
the relation between HIV-status and GBS carriage.
One million children die each year in the first 4 weeks of life because of neonatal disease1. Early-onset neonatal 
disease (EOD), which occurs in the first week of life and most often within 24 hours after birth, is caused by 
bacteria that are transmitted from the genital tract of the mother before or during delivery2. Late-onset neonatal 
disease (LOD) occurs between the first week and the third month of life and may be caused by bacteria acquired 
vertically or horizontally3.
Streptococcus agalactiae (Group B Streptococcus (GBS)), present in the vagina and/or gastro-intestinal tract 
of 20 to 30% of pregnant women, is the most common infectious agent identified in case of EOD4 and an impor-
tant pathogen in LOD5. Although vaginal carriage of GBS usually remains asymptomatic, it has been associated 
with chorioamnionitis6, spontaneous abortion7,8, premature labor9, premature delivery10, premature rupture of 
membranes11 and puerperal sepsis12,13, causing substantial neonatal and maternal morbidity and mortality1,2,14,15.
1Laboratory Bacteriology Research, Department of Microbiology, Immunology and Clinical Chemistry, Faculty 
of Medicine and Health Sciences, Ghent University, De Pintelaan 185, Ghent, Belgium. 2Department of Clinical 
Infection, Microbiology and Immunology, Institute of Infection and Global Health, University of Liverpool, Brownlow 
Hill, Liverpool, UK. 3HIV and Sexual Health Group, Department of Public Health, Institute of Tropical Medicine, 
Nationalestraat 155, Antwerp, Belgium. 4HIV/STI Reference Laboratory, Department of Clinical Sciences, Institute of 
Tropical Medicine, Nationalestraat 155, Antwerp, Belgium. 5Centre for Geographic Medicine Research - Coast, Kenya 
Medical Research Institute (KEMRI), PO Box 230-80108, Kilifi, Kenya. 6Nuffield Department of Medicine, University 
of Oxford, Headington, United Kingdom. 7Department of Obstetrics and Gynaecology, Vulvovaginal Disease Clinic, 
Ghent University Hospital, De Pintelaan 185, Ghent, Belgium. Correspondence and requests for materials should be 
addressed to P.C. (email: Piet.Cools@Ugent.be)
Received: 8 March 2017
Accepted: 20 September 2017
Published: xx xx xxxx
OPEN
www.nature.com/scientificreports/
2SCIenTIFIC REPORTS | 7: 13820  | DOI:10.1038/s41598-017-13218-1
Infants born to HIV-infected mothers have increased rates of infectious morbidity and mortality compared to 
non-exposed infants, even if they remain HIV-uninfected16,17. Since the first study reporting an increased risk of 
GBS neonatal disease in HIV-exposed neonates17, evidence for this association has been accumulating.
A possible explanation for these observations might be higher rectovaginal GBS carriage rates in HIV-infected 
women, as rectovaginal GBS carriage is a major risk factor for GBS neonatal sepsis.
Indeed, HIV might influence the microbial composition of the vagina, rectum and colon18–22 and HIV infec-
tion in women has been associated with increased prevalence of vaginal candidiasis and sexually transmitted 
infections23,24. However, conflicting results have been reported for the association between HIV infection and 
rectovaginal carriage of GBS25,26.
The objectives of this systematic review and meta-analysis were to assess to which extent HIV exposure of 
neonates is associated with GBS neonatal disease and to clarify to which extent HIV infection of women is asso-
ciated with rectovaginal GBS carriage, a major risk factor for GBS neonatal disease.
Research in context
Evidence before this study. Mother-to-child transmission of HIV is one of the great tragedies of the HIV 
pandemic. Although the number of HIV-infected infants is declining due to interventions for the elimination of 
pediatric HIV infection, the number of newborns that are HIV-uninfected but HIV-exposed through their HIV-
infected mothers is on the rise. Interest in the health outcomes of these HIV-exposed infants has grown in the past 
decade, and several studies suggest increased mortality rates and increased infectious morbidity.
Neonatal sepsis causes one million neonatal deaths yearly, and Group B Streptococcus (GBS) is the leading 
cause. Since 2010, evidence has also been accumulating for an association between HIV-uninfected neonates 
born to HIV-infected mothers and neonatal sepsis caused by Group B Streptococcus (GBS). Regarding the asso-
ciation between maternal vaginal GBS carriage – the single most important risk factor, if not, a prerequisite, for 
GBS neonatal sepsis – and HIV-infection in mothers, conflicting results have been reported.
Added value of this study. To our knowledge, this systematic review and meta-analysis is the first to exam-
ine the association between HIV-exposure of neonates and the risk for neonatal disease caused by GBS. We 
performed subgroup analysis to further clarify the risk for the early-onset form of GBS neonatal sepsis, and the 
late-onset form. Furthermore, we performed a meta-analysis to assess the risk for maternal vaginal GBS carriage 
in HIV-infected compared to uninfected women. We present a pathogenic framework, explaining our findings 
regarding the associations between neonatal HIV-exposure and early-and late-onset neonatal sepsis. This frame-
work offers opportunities for the clinical practice and global health policy to reduce HIV-related neonatal mor-
bidity and mortality rates.
Implications of all the available evidence. Neonates born to HIV-infected mothers, but themselves 
uninfected, are at increased risk for GBS neonatal sepsis. Subgroup analysis showed that these neonates were four 
times more likely to have the GBS late-onset form, but were not at increased risk for the early-onset form. We 
found no association between maternal vaginal GBS carriage and HIV-infection, but included studies suffered 
from major limitations.
The health needs of HIV-exposed, uninfected infants should be prioritized further. Particularly in sub-Saharan 
Africa, were 90% of new HIV infections occurs and the burden of neonatal mortality is the highest, public health 
interventions reducing neonatal mortality rates are urgently needed. Feeding strategies should be explored to 
reduce LOD in infants born to HIV-infected mothers.
Methods
Protocol and registration. We followed the Preferred Reporting Items for Systematic Reviews and Meta-
Analyses (PRISMA) guidelines27 for carrying out and reporting this systematic review and meta-analysis, using 
an a priori defined protocol. This systematic review and meta-analysis has been registered in PROSPERO under 
registration number CRD42016033414.
Eligibility criteria. We included studies that assessed the association between neonatal GBS disease and 
HIV-status of the mother and studies that assessed the association between rectovaginal GBS colonization and 
HIV status in adult women. We only included studies that reported a sample size and a measure of effect for the 
associations assessed or provided the data to calculate the latter. There were no restrictions in terms of study 
design, manuscript language, or date of publication. We included papers that were published up to 1 November 
2015.
Reviews, conference abstracts, comments, guidelines, case reports or case series, unpublished articles, mul-
tiple reports of the same data and in vitro and animal studies were not considered for inclusion. We excluded 
studies that had no clear description of the assessment of the HIV status of the women, of the HIV exposure of the 
neonates, or of the laboratory methodology to assess rectovaginal GBS carriage. GBS neonatal disease was defined 
as the presence of GBS as assessed by molecular methods, culture from blood, cerebrospinal fluid or another nor-
mally sterile site, or by latex agglutination in cerebrospinal fluid, in neonates below 90 days of age.
Search strategy. We searched the MEDLINE (through PubMed), Web of Science, and EMBASE databases 
for bibliographic references. We used the combination of all of the following search terms (Streptococcus aga-
lactiae, S. agalactiae, GBS, Group B Streptococcus, Group B streptococci, early-onset disease, early-onset sepsis, 
late-onset disease, late-onset sepsis, neonatal sepsis, neonatal septicemia, neonatal pneumonia or neonatal men-
ingitis) with all of the following search terms (human immunodeficiency virus, HIV, HIV-1, or AIDS).
The bibliographic references of the studies that were considered eligible were also hand searched.
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Study selection. Studies were selected in a two-stage process (Fig. 1). First, all bibliographic references were 
screened to identify studies for full text evaluation by one reviewer (PC), on the basis of only the information 
present in the title and abstract. Subsequently, the full texts of those articles not excluded in the screening pro-
cess were assessed for eligibility, using the aforementioned criteria, by two authors independently (PC and MV). 
Reasons for inclusion or exclusion were recorded and categorized, and disagreements were resolved by consensus 
(Supplementary Table 1).
Selected studies were divided into two categories, i.e. studies reporting an association between HIV-exposure 
and GBS invasive neonatal disease in infants (or providing data to calculate this), and studies reporting an associ-
ation between HIV infection and rectovaginal GBS carriage in adult women (or providing data to calculate this).
Data collection process. A predefined data extraction form was pilot-tested and used for data extraction. 
From each individual study, information was collected on authors, year of publication, journal, country where the 
study had been carried out, study design, sample collection period, study population, age of the participants, total 
Figure 1. Identification of studies included in the meta-analysis. #Including two studies reporting on neonatal 
GBS disease; ##including two studies reporting on rectovaginal carriage.
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number of study participants, total number of samples included in the analysis, HIV assessment and prevalence, 
GBS neonatal disease assessment and incidence, rectovaginal GBS carriage assessment and prevalence, relevant 
measures of effects, statistics, correction for confounding, and epidemiological strengths and weaknesses.
This procedure was performed for each article independently by two authors (PC, and TC, VJ, ES, JVDW or 
MV) and disagreements were resolved by discussion between both authors. Further information or clarification 
from manuscript authors was sought by PC on seven occasions.
Risk of bias in individual studies. To assess the quality and risk of bias of the included studies, we devel-
oped a quality appraisal tool (Supplementary Table 2), based on the Newcastle-Ottawa Scale28. This scale is a 
bias assessment tool for observational studies, recommended by the Cochrane Collaboration29. We adapted this 
tool to the content of the meta-analysis. For example, consideration was given to the methodology used to assess 
rectovaginal GBS carriage.
Stars were assigned by PC for three broad criteria (representativeness of the study groups, comparability of 
the study groups, and quality of the outcome assessment) in order to provide a measure of their quality. In this 
context, good representativeness is defined as those exposed/unexposed being similar to others in the community 
they come from, and good comparability is defined as the exposed and unexposed being similar in all respects 
other than their HIV or HIV exposure status.
Studies that scored none or one, two or three, or four stars for representativeness were classified as having 
respectively a high, medium or low risk of bias for this criterion. Studies assigned none, one, or two stars for com-
parability or outcome were considered to have respectively a high, medium or low risk of bias for comparability 
and outcome.
Data analysis. First, an odds ratio (OR) was calculated for studies that did not present them. We com-
pared the odds of neonatal GBS disease in neonates born to HIV-infected mothers versus infants born to 
HIV-uninfected mothers, and the odds of rectovaginal GBS carriage in HIV-positive versus HIV-negative 
women, using unadjusted counts. All neonates born from HIV-positive women were considered as HIV-exposed, 
regardless of their infection status. Rectovaginal GBS carriage was defined as GBS detected in the vagina and/
or rectum and/or (peri)anal region by culture. While our protocol also included detection of rectovaginal and 
neonatal GBS by molecular testing, none of the eligible studies used molecular testing, and the results reported in 
this manuscript are based on culture and latex agglutination results only.
We reported the results of the meta-analyses obtained after pooling individual study estimates with random 
effects model as ORs with 95% confidence interval (CI). The degree of heterogeneity between the studies was 
assessed using the I2 index, with percentages of 30–50%, 50–75% and 75–100% being indicative of moderate, 
substantial and considerable heterogeneity, respectively30.
A priori planned subanalyses were performed for GBS neonatal disease by considering early-onset and 
late-onset neonatal GBS disease separately, relying on the authors’ own classification into these two groups.
To assess publication bias, funnel plots were created by plotting the natural logarithm of the ORs against the 
inverse of the standard error. The asymmetry of the funnel plots was visually inspected and statistically checked 
using Egger’s regression test and Begg and Mazumdar’s rank correlation test31,32. All statistical analyses were car-
ried out using the Comprehensive Meta-Analysis software package v3 (Biostat Inc., Englewood, NJ).
Role of the funding source. The funder of the study had no role in study design, data collection, data anal-
ysis, data interpretation, or writing of the report.
Results
Manuscript and study selection. A total of 546 unduplicated citations were identified, we selected 81 
abstracts for full text evaluation (Fig. 1). Of these, 32 manuscripts did not report results on GBS disease or car-
riage or HIV exposure, seven were reviews, book chapters or letter to editors, nine did not include an HIV-
negative or GBS-negative group, 11 did not present measures of effect or the data to calculate these, four reported 
already published data, and one paper could not be found (Supplementary Table 1).
Seventeen manuscripts reporting on 19 studies met the inclusion criteria. These included four studies report-
ing on neonatal GBS disease only, 11 studies reporting on rectovaginal carriage only, and two studies reporting 
both (Fig. 1). A list of these studies and a digest of the extracted information is presented in the Supplementary 
Tables 3 and 4.
Description of selected studies. Six studies, reporting a total of 252,051 births, reported cases of infants 
with GBS neonatal disease born to HIV-infected mothers compared to infants with GBS neonatal disease born to 
HIV-uninfected mothers17,33–37. Five of these studies were conducted in South Africa33–37 and one was performed 
in Belgium17. All infants included were born in a hospital. For the laboratory diagnosis of GBS neonatal disease, 
all studies used the BacT/ALERT microbial detection system to detect bacteria in blood and/or cerebrospinal 
fluid samples. Positive samples were subcultured on blood agar plates and identification was subsequently per-
formed using standard identification methods.
For the second category, thirteen studies, representing a total of 10,105 women, provided rectovaginal GBS 
carriage ratios of HIV-infected versus HIV-uninfected women7,25,26,34,35,38–45. Eleven of these studies were con-
ducted in low-or-middle income countries, i.e. three studies in South Africa34,35,43, two studies in Tanzania39,41, 
and one study in Burkina Faso, Brazil, Democratic Republic Congo, Kenya, Malawi, and Zimbabwe7,25,26,38,40,42 and 
two in a high-income country namely Spain and the US44,45. All these studies recruited pregnant women in a hos-
pital setting, except for the study of Djigma and coworkers in Burkina Faso (2011), who recruited non-pregnant 
women, and the study of Ulla and coworkers in Spain (1993), who recruited female sex workers attending a family 
planning center.
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Rectovaginal GBS carriage was assessed by culture in all studies: five studies performed rectovaginal sampling 
and culturing with the use of an enrichment broth, as recommended by the Centers for Disease Control and 
Prevention (CDC) guidelines26,40–42,44, two studies only sampled vaginally with cultures performed according 
to the CDC guidelines34,35 and the remaining six studies did not culture according to CDC guidelines or did not 
report the exact culture methods used7,25,38,39,43,45.
Of the 19 studies described of the 17 manuscripts, three were retrospective17,37,44, fourteen were 
cross-sectional7,25,26,33–36,39–43 and none were prospective.
One study reported two different analyses for rectovaginal GBS carriage in HIV-infected versus uninfected 
women, i.e. using the total cohort versus matched subsets35. The analysis least prone to bias (i.e. the matched 
subsets) was used for this meta-analysis. The same study analyzed matched subsets for the association of HIV 
exposure of neonates and GBS neonatal disease and early-onset GBS neonatal disease, but not for late-onset GBS 
neonatal disease. Therefore, we used the total cohort analysis for these associations.
Risk of bias within studies. The results of the critical appraisals of the included studies are shown in Fig. 2 
and Supplementary Table 5. All six studies addressing the relationship between HIV exposure of neonates and 
GBS neonatal disease were assessed as having a low risk of bias for representativeness17,33–37. Two out of the six 
studies had a low risk of bias for comparability33,35, two had a medium risk34,36 and two had a high risk17,37. For 
the GBS disease outcome assessment, four studies were assessed as having a low risk of bias33,35–37 and two had a 
medium risk17,34.
Of the studies on HIV infection and maternal GBS carriage only two out of the thirteen studies were assessed 
as having a low risk of bias for representativeness35,40, nine studies a medium risk7,25,26,34,39,41–43,45 and two studies 
a high risk38,44.
Three out of the thirteen studies were assessed as having a low risk of bias for comparability35,40,44, four a 
medium risk34,39,41,43, and six a high risk7,25,26,38,42,45. The risk of bias for outcome assessment was low in five out of 
the thirteen studies26,40–42,44; medium in two studies34,35 and high in six studies7,25,38,39,43,45.
Association of maternal HIV status with GBS neonatal disease. The meta-analysis of the associa-
tion between HIV exposure of neonates and GBS neonatal disease showed that HIV-exposed neonates were more 
than twice as likely to have neonatal GBS disease compared to unexposed neonates (OR, 2.39; CI, 1.31–4.38; 
p = 0.005) (Fig. 3). The crude OR in the individual studies ranged from 1.72 to 19.86, with three of the six indi-
vidual studies showing a statistically significant association. The subanalyses showed that HIV-exposed neonates 
were not at increased risk for early-onset neonatal disease (OR, 1.31; 95% CI, 0.84–2.04; p = 0.240), but were 4.43 
times more likely to have late-onset neonatal disease (95% CI, 1.81–10.85; p = 0.001).
As recommended by Sterne and co-workers (2011)46 to only create funnel plots when the number of studies is 
ten or more, we did not create a funnel plot for this meta-analysis.
Association of HIV infection and rectovaginal GBS carriage. In our meta-analysis of the association 
between HIV infection and rectovaginal GBS carriage, we found no significant association between HIV infec-
tion status and rectovaginal GBS carriage (OR 1.09; 95% CI 0.82–1.44; p = 0.55) (Fig. 4). The crude ORs in the 
Figure 2. Quality assessment using an adapted Newcastle-Ottawa Scale for risk of bias of studies included in 
the systematic review. Left, studies (n = 13) reporting an association between HIV infection and rectovaginal 
GBS carriage. Right, studies (n = 6) reporting an association between neonatal HIV exposure and neonatal GBS 
disease. The absolute numbers of studies are shown in the boxes.
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Figure 3. Forest plot of estimates of association between HIV exposure and GBS neonatal disease. Studies 
are plotted alphabetically according to the last name of the first author and followed by the publication year. 
Each study is represented by a black square and a horizontal line, which corresponds to the OR and 95% CI, 
respectively. The areas of the black squares reflect the weight of the study (determined by random effects 
analysis) in the meta-analysis. The vertical line in the middle corresponds to an OR of 1.0. The diamonds 
represents the overall summary estimate for EOD, LOD and total GBS disease, respectively, with the 95% CIs 
given by the width. In the columns on the right, the number of cases on the total number of HIV-positive and 
of HIV-negative mothers is given, respectively, for each study. aDangor, 2015, JID; bDangor, 2015, PONE; CI, 
confidence interval; OR, odds ratio; //95% CI line exceeding OR 100.
Figure 4. Forest plot of estimates of association between HIV infection and rectovaginal GBS carriage. Studies 
are plotted alphabetically according to the last name of the first author and followed by the publication year. 
Each study is represented by a square and a horizontal line, which corresponds to the OR and the 95% CI, 
respectively. The magnitude of the squares reflects the weight of the study (determined by random effects 
analysis) in the meta-analysis. The vertical line in the middle indicates the OR 1.0. The diamond at the bottom 
represents the summary estimate, with its width indicating the 95% CI. The two columns on the right document 
the number of GBS cases on the total of HIV-positive and of HIV-negative women, respectively, for each study. 
aDangor, 2015, JID; CI, confidence interval; OR, odds ratio; bold, p < 0.05.
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individual studies ranged from 0.26 to 4.22, with only three studies reporting a statistically significant associa-
tion7,25,35. Two of these studies found a significantly higher rectovaginal carriage rate in HIV-positive women7,25, 
whereas one study found a significantly lower rate35.
The heterogeneity among these studies is substantial (I2 = 68.7%). Visual inspection of the funnel plot shows 
an asymmetrical distribution of studies, suggesting publication bias (Fig. 5), which is marginally supported by 
Egger’s regression intercept (0.94; 95% CI −0.48–2.37; p = 0.09), but not by the Begg and Mazumdar’s rank cor-
relation test (Kendall’s tau = −0.10, one-tailed p-value = 0.313). Two studies7,25 fall outside the pseudo 95% con-
fidence interval, providing further evidence of heterogeneity and bias.
Discussion
Group B streptococci (GBS) are a major cause of neonatal sepsis, which results in one million neonatal deaths 
every year1. Also, studies have repeatedly shown that HIV-negative neonates that had been exposed to HIV 
during pregnancy are at increased risk for infectious morbidity and mortality (reviewed in47). In this system-
atic review and meta-analysis, we assessed the risk for GBS neonatal disease in HIV-exposed neonates. We also 
assessed the risk for rectovaginal GBS carriage in HIV-infected women, as rectovaginal carriage is a major risk 
factor for neonatal GBS disease.
We found convincing evidence that HIV-exposed neonates were at higher risk for GBS neonatal disease. 
When analyzing cases of early-onset GBS and late-onset GBS disease separately, we found that this increased risk 
pertains to late-onset disease only.
There are several factors associated with HIV infection in pregnant women or mothers that might explain why 
infants born to HIV-infected mothers are at increased risk for late-onset, but not early-onset GBS disease. In the 
case of early-onset GBS disease, the factors that increase or decrease the risk for early-onset GBS disease might be 
well-balanced, while in the case of late-onset GBS disease, the net result may be an enhanced risk (Fig. 6).
Factors that might decrease early-onset GBS disease rates in HIV-exposed neonates. Antibiotic 
prophylaxis. HIV-infected pregnant women widely use antibiotic prophylaxis (co-trimoxazole), as recom-
mended by the World Health Organization (WHO)48. Co-trimoxazole, largely effective against GBS41, is likely 
to be responsible for lower GBS rectovaginal carriage rates in HIV-infected pregnant women. For instance, we 
previously showed, using GBS-specific quantitative PCR (qPCR), that none of 30 Rwandan HIV-infected women, 
of which 93.3% were on antibiotic prohylaxis, carried GBS49. Seale and coworkers found that the rectovaginal GBS 
carriage rate was significantly less in 161 HIV-positive women on co-trimoxazole prophylaxis (n = 161, 3.1% GBS 
positive) compared to HIV-positive women not on prophylaxis (n = 239, 8.4% GBS positive) and compared to 
HIV-negative women (n = 7285, 12.1% GBS positive)50. As in GBS EOD, GBS is thought to be transmitted to the 
neonate from the vagina during passage through the birth channel or, more commonly, to the fetus in utero after 
breaking of the membranes by an ascending infection from the vagina, reduction of vaginal GBS carriage rates 
might reduce the risk for the early-onset form, but not for the late-onset form, where GBS is considered to be 
more frequently community- or hospital-acquired, or acquired through gut translocation. Antibiotic prophylaxis 
might also lead to neonatal gut dysbiosis: see further.
Figure 5. Funnel plot to assess publication bias among studies evaluating the association between HIV 
infection and rectovaginal GBS carriage. The circles represent the estimates of the 11 included studies of 
association between HIV infection and rectovaginal GBS carriage. The log of the odds ratio is plotted on the 
horizontal axis, against the inverse of the standard error of the odds ratio on the vertical axis. The vertical line 
in the funnel plot indicates the fixed-effects summary estimate and the sloping lines indicate the expected 95% 
confidence intervals for a given standard error.
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Caesarean delivery. The prevalence of EOD might be reduced by the practice of elective caesarean section. 
Elective caesarean section, i.e. caesarean delivery before labor and before rupture of membranes, has been shown 
to reduce the risk of mother-to-child transmission of HIV by 80% (60% to 70% of mother-to-child transmissions 
occur during labor and vaginal delivery51,52. This has led to dramatically increased ECS rates in HIV-infected 
Figure 6. Framework explaining a higher prevalence of LOD (but not of EOD) in HIV-uninfected infants born 
to HIV + mothers compared to HIV- mothers. (1): lower concentrations of anti-GBS antibodies and cytokines 
in the circulation of HIV + mothers compared to HIV- mothers (↑EOD,↑LOD); (2): reduced transplacental 
transfer rate (symbolized by the narrower arrow) of anti-GBS antibodies and cytokines in HIV + mothers leading 
to reduced fetal immunity (↑EOD,↑LOD); (3): antiretrovirals in circulation of HIV + mothers might cause 
neonatal immune dysfunction (↑EOD,↑LOD); (4): higher rates of caesarean section in HIV + women compared 
to HIV- women (symbolized by the broader arrow), leading to a lower risk of GBS transmission during vaginal 
birth but also leading to neonatal gut dysbiosis (↓EOD,↑LOD); (5): antibiotic prophylaxis in HIV + women 
reduces vaginal carriages rates of GBS and hence risk GBS transmission during vaginal birth but is a contributor 
of neonatal gut dysbiosis (↓EOD,↑LOD); (6): lower prevalence of breastfeeding (symbolized by the narrower 
arrow) in HIV + mothers compared to HIV- mothers leading to a reduced passive immunity in their newborns 
and to neonatal gut dysbiosis (↑LOD); (7): neonatal gut dysbiosis leading to a reduced gut immunity and bacterial 
translocation (↑LOD); (8): HIV-infected women are at higher risk of having al low birth weight infant or a preterm 
delivery, both risk factors for EOD and LOD (↑EOD,↑LOD). ↓ = lower risk of, ↑ = higher risk of.
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women in some countries52. Because of the modes of transmission of GBS in EOD and LOD (see ‘antibiotic 
prophylaxis’), ECS might reduce the risk for EOD but not for LOD. Interestingly, Wu and coworkers found that 
of the 28 EOD cases, significantly more were born by vaginal delivery compared to cesarean delivery (64.3 versus 
35.7%, respectively). Mehar and coworkers studied 141 cases of neonatal sepsis (61.3% EOD and 39.7% LOD). Of 
the neonates born by vaginal delivery, 38.1% became septic compared to 21.2% who were delivered by cesarean 
section53. Hook and colleagues54 compared pregnancy outcomes among 497 women undergoing elective repeat 
cesarean delivery to 492 who attempted trial of labor and 989 women with routine vaginal delivery. They found 
that rates of suspected and confirmed neonatal sepsis were significantly lower in the elective repeat cesarean deliv-
ery group, although absolute numbers of cases were very small (9, 26 and 26 cases of suspected sepsis in elective 
repeat cesarean delivery, trial of labor and vaginal delivery, respectively; and 0, 4 and 1 cases of confirmed sepsis 
in elective repeat cesarean delivery, trial of labor and vaginal delivery, respectively). Caesarean delivery might also 
lead to neonatal gut dysbiosis: see further.
Factors that might increase late-onset GBS disease rates in HIV-exposed neonates. Formula 
feeding. Since 2009, the WHO recommends HIV-positive mothers to practice exclusive breastfeeding for 
their infants in combination with antiretroviral therapy (ART) for mother or infant. However, compared to 
HIV-negative women, HIV-positive women have been shown to preferentially choose exclusive replacement feed-
ing or mixed feeding, or stop breastfeeding early, because of fear of HIV transmission through breast milk. This 
is a consequence of previous WHO guidelines recommending total avoidance of breastfeeding and/or because 
many advocates of programs for prevention of mother-to-child transmission recommend early weaning55–61. Lack 
of breastfeeding might hamper passive protection of the neonate against GBS neonatal disease as GBS specific 
IgA, present in breast milk, could offer GBS-specific protection62. Furthermore, HIV-infected mothers might have 
reduced IgA in breast milk, as has been shown to be the case for saliva63. These altered infant feeding practices are 
likely to have more effect on the incidence of LOD, considering the fact that most infants with EOD are already 
septic at birth or become septic shortly after birth.
Many other bioactive factors in breastmilk, such as growth factors and prebiotics, may contribute to a better 
immune response and development and these children are likely more resistant to infectious diseases64. This has been 
exemplified by some trials, where breastfed children born to HIV-positive mothers has significantly lower mortality 
rates compared to formula-fed children65,66. Formula feeding might also lead to neonatal gut dysbiosis: see below.
Neonatal gut dysbiosis. The human gut microbiome is involved in many aspects of health and disease by exerting 
metabolic, nutritional, and immunological effects on the host67. In healthy, vaginally delivered and term new-
borns, pioneering bacteria from the mother are encountered, tolerated and regulated by the naïve neonatal gut 
immune system. In turn, this emerging microbiome sculpts the gut immune, metabolic and barrier function67,68. 
This dynamic process is readily disrupted. Such disruption, termed dysbiosis, appears to be pivotal in develop-
ment of LOS67,69,70. Neonatal gut dysbiosis compromises the integrity of the intestinal barrier and the develop-
ment of the immune system, leading to an increased risk for bacterial gut translocation into the bloodstream of 
the neonates69,71,72.
The most important disturbing factors of the neonatal gut microbiome appear to be (i) C-section delivery, (ii) 
perinatal maternal and/or neonatal antibiotic use, and (iii) formula feeding73.
 (i) The gut microbiome differences between neonates born by vaginal delivery and caesarean section are 
striking. A landmark study by Dominquez-Bello and coworkers found that the former harbored a gut 
microbiome closely resembling their mother’s vaginal bacteria (e.g. lactobacilli), while the latter harbored 
a gut microbiome resembling that of the maternal skin (e.g. Staphylococcus, Corynebacterium, Propionibac-
terium spp.)74. Other studies have confirmed that neonates born by caesarean section have disturbed gut 
microbiomes compared to neonates born by vaginal delivery (reviewed in75).
 (ii) Multiple studies have shown that peripartum antibiotics disrupt the natural neonatal microbiome as-
sembly73. For example, intrapartum antibiotics to prevent neonatal GBS disease has been associated with 
decreased bacterial diversity of the meconium76 and lower abundance of lactobacilli and bifidobacteria in 
the neonatal gut73. Administration of antibiotics to the neonate directly after birth has been associated with 
gut dysbiosis73 and with LOS77.
 (iii) Formula feeding can cause perturbations of the neonatal gut microbiome compared to breast milk, even if 
given in small amounts during breastfeeding73. Breast milk contains a mix of nutrients, bacteria, antimicro-
bial proteins and secretory IgA that affects the shaping of the normal neonatal gut microbiome. Formula 
milk has for example been associated with a decreased prevalence of bifidobacteria78, thought to suppress 
the growth of potentially pathogenic bacteria79. Clinical studies have shown that lack of breastfeeding is 
a risk factor for neonatal LOD and meningitis80–82, and it is tempting to hypothesize that the mechanistic 
pathway explaining these findings is a combination of the above-discussed consequences of formula feed-
ing/lack of breastfeeding, ie. a reduced passive immunity and a dysbiotic gut microbiome.
The risk of bacterial translocation causing LOS is exacerbated in preterms and neonates with (very)-low birth 
weight: these are not only at higher risk of the above-mentioned risk factors leading to gut microbiome dysbiosis, 
but also have an increased intestinal permeability and an immature immune system79.
Factors that might increase EOD and LOD GBS disease rates in HIV-exposed neonates. 
Compromised immunity. Low maternal GBS-specific antibody concentrations have been shown to be corre-
lated with susceptibility of neonates for GBS EOD and LOD83–85. Some important observations show that these 
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protective antibodies are reduced in HIV-exposed neonates and HIV-infected mothers. Significantly lower 
GBS-specific antibody concentrations were measured in maternal/cord blood from HIV-infected mothers and 
neonates born from HIV-infected mothers34,86. Furthermore, a reduced transplacental transfer of GBS-specific 
antibodies has been shown in HIV-infected mothers34,86. In addition, the neonatal anti-GBS antibodies remained 
significantly lower at 16 weeks86. Le Doare and co-workers demonstrated a significantly lower antibody-mediated 
C3b/iC3b deposition on all investigated GBS serotypes (Ia, Ib, II, III and V) in HIV-infected women and neonates 
born to HIV-infected women, suggesting a reduced opsonophagocytotic immune effector function86. A recent 
phase 2 GBS vaccination trial (with a trivalent vaccine consisting of conjugated capsular polysaccharides of GBS 
serotypes Ia, Ib and III) in African HIV-positive and HIV-negative pregnant women showed that the vaccine was 
less immunogenic in HIV-infected women, irrespective of their CD4 count87.
Other perturbations of the immune system of HIV-infected women (even in the absence of overt immune 
dysfunction) might also play an important role. HIV-infected women were shown to have reduced transplacental 
transfer of hematopoietic cytokines. This may result in lower thymic output of CD4+ cells in their infants and a 
delay in immune cell maturation17. Furthermore, intrauterine exposure to HIV or its soluble products appears to 
cause a disturbed thymic function in HIV-uninfected newborns88.
Anti-retroviral therapy (ART). ART, used to prevent mother-to-child transmission of HIV, might play a role as 
well. Nucleoside reverse transcriptase inhibitors (NRTIs) crossing the placenta could cause mitochondrial dys-
function in HIV-exposed uninfected infants, explaining a decrease in neutrophils, total lymphocytes, CD4+ and 
CD8+ cells counts17.
Prematurity and (very)-low birth weight. Prematurity and (very)-low birth weight are more prevalent in neo-
nates born to HIV-infected mothers (reviewed in89) and both are risk factors for GBS EOD and GBS LOD90–95.
Factors that might increase or decrease early-onset GBS disease rates in HIV-exposed neo-
nates: meta-analysis of the risk for rectovaginal GBS carriage in HIV-infected women. Because 
rectovaginal GBS carriage is a major risk factor for early-onset neonatal GBS disease, we also assessed the risk for 
rectovaginal GBS carriage in HIV-infected women.
Our meta-analysis, based on 13 studies, did not show an association between HIV infection and rectovaginal 
GBS carriage, but most of the studies suffered from major limitations and we consider the currently available 
evidence weak and call for further study.
Few studies had adequate statistical power and few were designed to assess the association between HIV infec-
tion and rectovaginal GBS carriage. Most studies were at medium or high risk of bias related to representativeness 
of study groups, comparability of study groups, and/or outcome assessment.
Heterogeneity was considerable. Technical biases, such as the specimen collection and culture methods are 
likely to contribute substantially to this heterogeneity. For example, rectovaginal sampling has been shown to 
yield significantly higher recovery rates compared to vaginal sampling alone96,97. Furthermore, the use of a selec-
tive enrichment broth has been shown to improve GBS detection substantially96,98. However, rectovaginal sam-
pling and the use of a selective enrichment broth, both recommended by the CDC, were used by only five studies. 
Also, the different study populations and eligibility criteria are likely to contribute to the observed heterogeneity.
Some important possible confounding factors were not taken into account. First, as described above, the use 
of antibiotic prophylaxis in HIV positive women, recommended by the WHO48, might be responsible for lower 
GBS rectovaginal carriage rates in HIV-infected pregnant women but was only taken into account in few studies. 
Secondly, none of the studies corrected for bacterial vaginosis (BV), a disturbance of the vaginal microbiome 
characterised by the deprivation of lactobacilli and the presence of anaerobes such as Gardnerella vaginalis and 
Atopobium vaginae. BV has been shown to be a risk factor for the acquisition of HIV99 but also to be negatively 
associated with vaginal GBS carriage49,100. Although speculatively, this might mask an association between HIV 
and GBS.
Finally, risk factors for early-onset GBS disease such as urinary tract infections and intrapartum fever have 
been reported to be more prevalent in HIV-infected women but were considered only by Cutland et al.35.
As the risk for EOD increases with heavier vaginal GBS colonization at the onset of labor or rupture of mem-
branes101, future studies should also include quantitative molecular tests such as GBS-specific qPCR to determine 
the vaginal GBS load in relation to the HIV status. Furthermore, including the assessment of GBS serotype/gen-
otype distribution in HIV-positive and –negative women will document whether more virulent GBS strains are 
present in HIV-positive women.
In conclusion, the evidence that HIV-exposed infants are at increased risk for late-onset GBS neonatal dis-
ease is accumulating. A compromised immune system, a neonatal gut microbiome dysbiosis, a lesser tendency 
to breastfeed but higher tendency for cesarean section and the use of prophylactic antibiotics in HIV-positive 
women might partly explain these findings. Public health interventions to prevent LOD are urgently needed in 
neonates born to HIV-infected mothers, even if themselves uninfected, and promoting feeding strategies such as 
breastfeeding or the use of probiotics and prebiotics have been shown to be exciting options to prevent69,81,82,102.
While we did not find evidence for an increased risk of rectovaginal GBS colonization in HIV-infected 
women, most studies conducted to date suffered major limitations. Further well-designed studies incorporating 
sensitive, quantitative (and serotype specific) GBS detection methods may further clarify the relation between 
HIV-positivity and GBS carriage.
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